[ad_1]
Bottles of prescription painkiller OxyContin tablets, made by Purdue Pharma LP sit on a counter at an area pharmacy in Provo, Utah, U.S., April 25, 2017.
George Frey | Reuters
A federal chapter choose stated on Friday he’ll approve a restructuring plan for drugmaker Purdue Pharma that features a $7.4 billion settlement resolving claims that it fueled the U.S. opioid epidemic via the sale of addictive ache medicines like OxyContin.
U.S. Chapter Decide Sean Lane, throughout a listening to in White Plains, New York, indicated he plans to log out on Purdue’s Chapter 11 plan, capping off a years-long chapter case that started in 2019, the Stamford, Connecticut-based firm stated.
Lane is predicted to concern a full, detailed choice on Tuesday.
“The plan is the product of intense work with our collectors via a singular, shared deal with delivering as a lot worth as potential to meaningfully deal with the opioid disaster,” Steve Miller, Purdue’s board chairman, stated in a press release.
Purdue filed for chapter in 2019 whereas going through greater than 2,600 lawsuits by states, native governments and others accusing it of contributing to the lethal opioid abuse epidemic via its advertising and marketing and sale of OxyContin and different ache medicines.
Purdue’s collectors embrace state and native governments, people who turned hooked on OxyContin, hospitals and others who had been harmed by the opioid disaster.
Its efforts to resolve their claims ran aground in 2024 when the U.S. Supreme Court docket rejected Purdue’s earlier chapter settlement and compelled the corporate to reduce authorized protections for its homeowners, members of the rich Sackler household, who had agreed to pay as much as $6 billion.
The ruling led Purdue to barter a brand new restructuring plan beneath which the Sacklers agreed to contribute $6.5 billion to $7 billion whereas collectors acquired the choice to choose out of waiving their claims and pursue their very own lawsuits as a substitute.
Members of the Sackler household have expressed remorse for his or her firm’s position within the opioid habit epidemic however deny wrongdoing.
Many of the settlement funds will likely be paid to U.S. state and native governments, who’ve agreed to make use of the cash for opioid abatement efforts comparable to habit remedy. Particular person opioid epidemic victims are entitled to obtain as a lot as $850 million.
After the chapter, Purdue will likely be transformed right into a nonprofit known as Knoa Pharma, which is able to deal with growing and distributing opioid overdose reversal and habit remedy medicines.
Purdue additionally agreed to create a public library of inner firm paperwork associated to its previous growth and advertising and marketing of OxyContin, together with the emails of Sackler members of the family.
[ad_2]
